Unibest
← Back to patent-cliff list

CAS 229625-50-7

di-tert-butyl (chloromethyl) phosphate

Codes: FOSR-002, FOST-004

Application context (from source-drug indications)

Radiation injuryL-Arginine hydrochloride/L-Lysine hydrochlorideImmune thrombocytopenic purpuraFostamatinib disodium hexahydrateThrombocytopeniaFostamatinib disodium hexahydrateViral pneumoniaFostamatinib disodium hexahydratePneumoniaFostamatinib disodium hexahydrateCOVID-19Fostamatinib disodium hexahydrateSevere acute respiratory syndromeFostamatinib disodium hexahydrateOnychomycosisFosravuconazole L-Lysine EthanolateChagas diseaseFosravuconazole L-Lysine Ethanolate

Source drugs (routes using this intermediate)

DrugTierExpiry
L-Arginine hydrochloride/L-Lysine hydrochlorideTier C — Watch / trade-
Fostamatinib disodium hexahydrateTier C — Watch / trade-
Fosravuconazole L-Lysine EthanolateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.

SupplierProductPrice bandMOQLead timeQualificationsAction
Qualified Partner — East China API Works6-Amino-2,2-dimethyl-2H-pyrido[3,2-B][1,4]oxazin-3(4H)-one
Pharmaceutical Intermediates
On requestOn requestOn request
—

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.